CINECA IRIS Institutional Research Information System

MOSCA, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.015
EU - Europa 4.899
AS - Asia 2.634
AF - Africa 358
SA - Sud America 44
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 22.976
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.669
IT - Italia 1.773
CN - Cina 1.148
SE - Svezia 1.105
BG - Bulgaria 747
SG - Singapore 736
CA - Canada 332
DE - Germania 327
GB - Regno Unito 305
VN - Vietnam 258
CI - Costa d'Avorio 190
TR - Turchia 189
FI - Finlandia 187
IN - India 122
UA - Ucraina 113
HK - Hong Kong 89
SN - Senegal 84
NG - Nigeria 57
FR - Francia 51
RU - Federazione Russa 48
BE - Belgio 45
CH - Svizzera 39
AT - Austria 31
ES - Italia 29
AU - Australia 18
BR - Brasile 18
JP - Giappone 18
CZ - Repubblica Ceca 17
ID - Indonesia 15
NL - Olanda 15
MY - Malesia 13
PL - Polonia 13
BJ - Benin 10
PT - Portogallo 10
MX - Messico 9
BD - Bangladesh 8
EG - Egitto 8
IE - Irlanda 8
AR - Argentina 7
RO - Romania 7
CL - Cile 6
EU - Europa 6
IR - Iran 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
IL - Israele 5
LT - Lituania 5
GR - Grecia 4
KR - Corea 4
PE - Perù 4
PK - Pakistan 4
RS - Serbia 4
ZA - Sudafrica 4
DK - Danimarca 3
HR - Croazia 3
PA - Panama 3
TH - Thailandia 3
TW - Taiwan 3
CO - Colombia 2
ET - Etiopia 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
OM - Oman 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HU - Ungheria 1
IQ - Iraq 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
PH - Filippine 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 22.976
Salva come PNG Salva come JPEG
Città #
Fairfield 1.855
Woodbridge 1.840
Houston 1.305
Ann Arbor 1.225
Chandler 1.136
Ashburn 911
Seattle 789
Sofia 745
Cambridge 620
Wilmington 593
New York 505
Milan 464
Boardman 434
Beijing 392
Singapore 366
Ottawa 317
Princeton 316
Lawrence 301
Medford 252
Abidjan 190
Des Moines 188
Serra 186
Izmir 181
Boulder 174
Nanjing 164
Florence 137
Jacksonville 135
San Diego 125
Dong Ket 119
Dearborn 116
London 111
Pisa 91
Dakar 84
Bremen 82
Hong Kong 81
Ogden 75
Redwood City 72
Rome 62
Lagos 57
Falls Church 56
Lancaster 55
Nanchang 55
Pune 45
Shanghai 41
Brussels 40
Livorno 40
Norwalk 40
Kunming 38
Shenyang 38
Frankfurt am Main 35
Fuzhou 35
Bern 34
Hebei 34
Changsha 31
Hefei 30
Vienna 27
Jiaxing 25
Guangzhou 24
Montecatini Terme 24
La Spezia 23
Tianjin 23
Jüchen 22
Quanzhou 22
Dallas 21
Los Angeles 21
Marseille 20
Munich 20
Santa Clara 20
Washington 19
Indiana 17
Helsinki 16
Hangzhou 14
Trani 13
Xiamen 13
Phoenix 12
Auburn Hills 11
Chengdu 11
Hyderabad 11
Jinan 11
Redmond 11
Brno 10
Cotonou 10
Villaviciosa de Odon 10
Warsaw 10
Zhengzhou 10
Bari 9
Detroit 9
Kent 9
Leawood 9
Palermo 9
Renton 9
San Mateo 9
Shenzhen 9
Tappahannock 9
Ariccia 8
Jakarta 8
Wuhan 8
Bogra 7
Dublin 7
Edinburgh 7
Totale 18.070
Salva come PNG Salva come JPEG
Nome #
null 179
Depression and systemic lupus erythematosus: a systematic review 170
null 151
Insomnia symptoms, perceived stress and coping strategies in patients with systemic lupus erythematosus 146
null 141
Assessment of disease activity in systemic lupus erythematosus. 139
Leukopenia, lymphopenia, andneutropenia in systemic lupus erythematosus: Prevalence and clinical impact--A systematic literature review 138
Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren's Syndrome 132
null 131
Mixed connective tissue disease. 129
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. 124
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 120
Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus 120
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus. 120
Prognostic value of flow mediated dilation in patients with systemic lupus erythematosus: A pilot prospective cohort study. 120
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience. 119
Muscular vasculitis confined to lower limbs: description of two case reports and a review of the literature 117
Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases 116
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force 116
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 116
The role of imaging in the evaluation of joint involvement in 102 consecutive patients with systemic lupus erythematosus 116
Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein 115
Poor sleep quality in systemic lupus erythematosus: does it depend on depressive symptoms 115
Platelet GPIIb/IIIa (P1A 1/2) polymorphism in SLE: clinical and laboratory association 113
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 113
Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. 113
null 112
Integrated backscatter analysis of carotid intima-media complex in patients with systemic lupus erythematosus 112
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 112
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 112
Undifferentiated connective tissue diseases (UCTD): Simplified systemic autoimmune diseases 111
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study 110
Systemic lupus erythematosus one disease or many? 108
Epidemiology and Management of Neuropsychiatric Disorders in Behçet's Syndrome. 108
null 107
null 107
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review 107
Undifferentiated connective tissue diseases (UCTD) 105
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases 105
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity 105
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. 105
null 104
Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. 104
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 103
miRNA-mediated regulation of Mucin-type O-Glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren's syndrome 103
Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy 102
clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen 101
Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. 101
The diagnosis and classification of undifferentiated connective tissue diseases. 100
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 100
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 100
Emerging trends in Sjögren's syndrome: basic and translational research. 99
Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus 99
Treat-to-target in systemic lupus erythematosus: where are we today? 97
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 97
Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology 96
Outcome of pregnancy in Italian patients with primary Sjögren syndrome 96
Pediatric Systemic Lupus Erythematosus: Learning From Longer Follow Up to Adulthood. 96
null 96
Personalization of biologic therapy in patients with rheumatoid arthritis: Less frequently accounted choice-driving variables 95
Sexual dysfunction in Behçet's syndrome 95
The economic impact of gout: a systematic literature review. 94
Vascular reactivity in patients with undifferentiated connective tissue diseases 94
A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone. 94
null 94
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 94
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) 94
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 93
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. 92
null 92
Undifferentiated connective tissue diseases in 2004 91
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation 91
null 91
The association of Sjögren syndrome and autoimmune thyroid disorders 91
Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome 91
null 90
A case of undifferentiated connective tissue disease: is it a distinct clinical entity? 90
Systemic sclerosis chronic ulcers: preliminary results of treatment with allogenic skin grafting in a cohort of Italian patients 90
Progressive sensorineural hearing impairment in systemic vasculitides 90
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. 90
LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus 89
Defining undifferentiated connective tissue diseases: a challenge for rheumatologists 89
null 89
null 89
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 89
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 89
Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine 89
Comparison of real-time PCR and nested PCR for the detection of Y chromosome sequences in the peripheral blood mononuclear cells of patients with systemic sclerosis 88
Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice 88
Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD. 87
Post-occlusive reactive hyperaemia (POHR) in systemic sclerosis: very early disease (VEDOSS) represents a separate entity compared to established disease. 87
null 87
Prevalence of thyroid dysfunctions in systemic lupus erythematosus. 87
Relapsing polychondritis: state of the art on clinical practice guidelines 87
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 87
[Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide] 86
Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) 86
null 86
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 86
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 85
Totale 10.435
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.677
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.180 0 0 0 326 406 471 472 393 444 292 286 90
2020/20212.267 133 162 168 71 142 78 434 218 249 147 134 331
2021/20223.303 105 154 66 214 608 538 107 161 134 153 208 855
2022/20233.699 523 495 234 325 417 454 53 258 634 23 247 36
2023/20243.115 221 264 302 169 429 598 300 120 66 39 219 388
2024/20251.009 64 408 248 289 0 0 0 0 0 0 0 0
Totale 23.726